8 Factors To Consider When Choosing a Drug Rehab Program

March 11, 2010 by · Leave a Comment

Facing the fact that someone you love is not only suffering from drug addiction, but now must receive help to overcome the addiction, is difficult for anyone. Where should you start? Who do you turn to? What questions do you need to ask about drug treatment programs? Perhaps, you may have been at this point before, and you now feel a sense of hopelessness in finding a residential treatment center that will work this time around. Maybe, though, this is the first time you’ve had to take these steps to help someone you love. The process can feel overwhelming.

Ultimately, you want your loved one back. You want that person you love free from drugs. You want that person to live a healthy and productive life. By asking the right question on each of the following areas when choosing a residential drug treatment center, your chances of making this happen for your loved one will increase.

1.Success Rate –
What is the success rate of the residential drug treatment center? Obviously, the higher the success rate, the more likely your loved one will succeed. Ask to speak with graduates of the drug rehab facility or their families. Get real opinions from real people.

2.Methods –
What method does the drug treatment center use? Ask yourself if they are addressing all aspects of your loved one’s addiction, including what led them to drugs in the first place. Methods that only deal with one aspect of addiction are more likely to fail. Remember addiction results from a combination of many factors, including a lessening of morality and integrity and an increasing burden of guilt and shame. The life of an addict includes bad habits, poor health and difficulty facing problems. After speaking with the facility, ask yourself if they are handling not just the psychological aspects, but also the physical and mental aspects of addiction as well. Are they providing practical skills that will help your loved one succeed once the drug rehabilitation program is completed?

3.Services –
What services does the residential drug treatment center offer? This is not only for your loved one, but for you as well. Will they help with legal issues? Will they assist in an intervention? In other words, to what length will they go to make certain your loved one gets the drug treatment they need?

4.Staff –
Who are the staff members at the residential drug treatment center? The best trained staff will have had experience with drug addiction. They will not have learned about it in a book. Are they qualified for their positions? What real-life knowledge do they have with drug addiction? What is their reason for working in this field?

5.Follow-up Program –
What type of follow-up program does the residential drug treatment center offer? This is important. Sending a newly rehabilitated drug addict back into the world without any follow-up can be disastrous. Make sure that there is a program of this type in place. Good programs keep in touch over the phone regularly after one leaves the program.

6.Location –
Where is the residential drug treatment center located? A residential drug treatment center should be protected. Ask how easy it would be for your loved one to leave. Many addicts when first coming off drugs want to leave. Ensuring that this is difficult, while not seeming like a prison, increases the chances that the person will stay to finish.

7.Length –
How long does the residential drug treatment center take? Although the standard program is 28 days, if the residential drug treatment center offers a longer program, it is more likely your loved one will succeed. However, if the residential drug treatment center allows your loved one to work at his or her own pace, without imposing time constraints, your loved one has an even greater chance of overcoming drug addiction.

8.Price –
How much does the residential drug treatment center cost? Before eliminating any program because of its price, ask yourself this: What are they offering? Look back at the points above and determine what the drug rehab is truly giving to the one you love. Yes, the more it offers, the more likely the price will be higher. However, your loved one will have a greater chance at becoming a healthy productive member of society. How much is that person worth to you?
Choosing a residential drug treatment center can be difficult. Dealing with a loved one suffering from drug addiction is devastating. By breaking the process down into what is important and finding out the answers to the questions above, you will be able to make an informed choice as to which residential drug treatment program can best help you and your loved one. Drug addiction can be dealt with and overcome.
By John Frank

Filed Under: drug addiction, pain medicine addiction, Recovery · Tagged: , , , , , , , , , , ,

Watch Video Channel 5 Pain Clinic Crisis in Florida

March 9, 2010 by · Leave a Comment

Channel 5 news reports about Florida’s problem with Pain Clinics, otherwise known as pill mills and pain management clinics. These pain clinics are targeting addicts of all kinds of substance abuse- Heroin, barbiturates such as Roxys and Oxicontin junkies. In this video you will see an addict who went to these pain clinics to get help with his pain pill addiction only to get further addicted to the pain medication. Sunrise Detox center located in Lake Worth Florida, and also has a location in New Jersey, is a detox center who agrees that there is a pain clinic crisis and these places are not helping the addict they are preventing them from getting sober and setting them up for a harder detox treatment.

Pain Medicine Addiction and Detox from http://sunrisedetox.com
//

Filed Under: drug addiction, pain medicine addiction, Prescription Drugs, Sunrise Detox Florida New Jersey, Sunrise Detox on Channel 5 News · Tagged: , , , , , , , , , , , , , , , , , , , , ,

F.D.A. to crack down on Pain Killer Clinics

March 6, 2010 by · Leave a Comment

F.D.A. to Place New Limits on Prescriptions of Narcotics

WASHINGTON — Many doctors may lose their ability to prescribe 24 popular narcotics as part of a new effort to reduce the deaths and injuries that result from these medicines’ inappropriate use, federal drug officials announced Monday.

A new control program will result in further restrictions on the prescribing, dispensing and distribution of extended-release opioids like OxyContin, fentanyl patches, methadone tablets and some morphine tablets.

These products are classified as Schedule II narcotics and already are restricted according to rules jointly administered by the Food and Drug Administration and the Drug Enforcement Agency. But the current restrictions have failed to “fully meet the goals we want to achieve,” said Dr. John K. Jenkins, director of the F.D.A.’s new drug center.

“What we’re talking about is putting in place a program to try to ensure that physicians prescribing these products are properly trained in their safe use, and that only those physicians are prescribing those products,” Dr. Jenkins said in a news conference on Monday. “This is going to be a massive program.”

Hundreds of patients die and thousands are injured every year in the United States because they were inappropriately prescribed drugs like OxyContin or Duragesic or they took the medicines when they should not have or in ways that made the drugs dangerous. The agency has issued increasingly urgent warnings about the risks, but the toll has only worsened in recent years.

The blame for this is shared among doctors who prescribe poorly, patients who pay little attention to instructions or get access to the medicines inappropriately, and companies that have marketed their products illegally.

The F.D.A. this year will hold meetings with manufacturers, patient and consumer advocates, and the public to ask for advice on how to carry out the new control program, officials announced. The first meeting will be on March 3, and no immediate changes in access to the drugs is planned.

The 24 medicines under review had 21 million prescriptions written for them in 2007, to 3.7 million patients, Dr. Jenkins said. They are extremely effective in reducing pain, which many medical studies suggest is widely undertreated in patients suffering serious illness. (A complete list of the drugs is at www.fda.gov/cder.)

But many doctors prescribe the drugs far too cavalierly, Dr. Jenkins said. The F.D.A. has received reports of patients’ being prescribed such medicines to treat something as simple as a sprained ankle, he said. In such patients, the medicines can be dangerous.

Part of the problem is marketing. Several reports, for instance, have suggested that Purdue Pharma, the maker of OxyContin, helped fuel widespread abuse of the drug by aggressively promoting it to general practitioners not skilled in either pain treatment or in recognizing drug abuse.

The company has denied such a connection, but a holding company connected with Purdue and three top Purdue executives pleaded guilty last year to criminal charges that the company had misled doctors and patients by claiming for five years that OxyContin was less prone to abuse because it was a long-acting narcotic.

Doctors are also to blame. A common reason for disciplinary actions at state medical boards is the use of narcotics in patients who show clear signs of addiction or for whom the drugs are obviously inappropriate.

The F.D.A. generally avoids interfering with the practice of medicine because doctor behavior is governed by state medical boards. Instead, the agency usually tries to provide doctors with the best and most current information, and then allows them to decide how to use it.

Most of the drugs withdrawn over the last 20 years, however, were taken off the market because doctors continued to use the medicines in ways that the F.D.A. warned against.

For decades, the agency’s armory in these battles held only a popgun and a cannon — the popgun being the issuance of widely ignored warnings; the cannon being its ability to force a medicine’s withdrawal. But a law passed in 2007 gave the agency a new, intermediate weapon — Risk Evaluation and Mitigation Strategies. Known as REMS, these programs allow the agency to place strong restrictions on the distribution of certain drugs.

Filed Under: drug addiction, Prescription Drugs, Sunrise Detox Florida New Jersey · Tagged: , , , , , , , , , , , ,

Do Genetics Cause Drug Addiction?

February 27, 2010 by · Leave a Comment

The role of genetics in addiction has been debated for decades. Scientists and other health experts have successfully identified various risk factors for the development of addiction, but concise and objective predictors of drug addiction have eluded discovery. This past year, however, science has made significant strides in discerning how genetics may affect addiction.

A landmark scientific paper published in the April 2009 issue of Nature Reviews Genetics presented some groundbreaking new insights into the role of genetics in addiction by honing in on specific genes that are tied to all types of addictions. The study, conducted by addiction experts at the University of Virginia Health System and the University of Michigan, even found that some genes that are associated with alcohol dependence are also linked to various other  addictions. The gene was found to be a common factor in addictions to nicotine, cocaine, opioids and other substances.

Study co-author Ming Li, Ph.D., professor of psychiatry and neurobehavioral sciences at the UVA School of Medicine, commented on the study and its potential impact:

“Addiction researchers have found that several genes are linked with multiple addictions. … So, we’re narrowing the scope to specific genetic targets. Once researchers can pinpoint exact genetic variants and molecular mechanisms, then we can create much more effective, even personalized, treatments for individuals addicted to a variety of substances.”

Li also believes that further research is needed to understand the full impact of genetic variations on addiction. “The exact nature of the gene variants and how they function are still unknown, so functional studies as well as studies using additional ethnic population samples may be quite revealing,” Dr. Li said.

Another recent study, conducted by researchers at the University of Colorado in Denver, pinpointed genetic pathways and genes associated with alcohol consumption. The researchers were able to identify genetic factors that predisposed both rats and humans to drink more; however, they were unable to discover a similar link between the genes and actual alcohol addiction. Nonetheless, according to Boris Tabakoff, a lead researcher, the study’s results may help scientists to eventually connect the dots between genetic makeup and addiction.

Tabakoff said, “We know that high levels of alcohol consumption can increase the risk of becoming alcohol dependent in those who have a genetic makeup that predisposes to dependence. This is a case of interaction between genes and environment. Indeed, in our study we found that, higher alcohol consumption in humans was positively correlated with alcohol dependence. However, because different sets of genes seem to influence the level of alcohol consumption, as opposed to propensity for alcohol dependence, we are confronted with great variation in humans. Individuals with a set of genes that predisposes them to drink moderate amounts of alcohol may still have the genetic predisposition to lose control over their drinking behavior, and perhaps become alcohol dependent. Conversely, individuals with a genetic predisposition to drink high amounts of alcohol may not have the genes that predispose them to become dependent.”

A study just completed at Brown University (the results will be published in the January 2010 issue of Alcoholism: Clinical & Experimental Research) succeeded in identifying a link between a gene variation and teen alcohol misuse. For the study, researchers examined the genetic makeup of 187 adolescents (98 boys and 89 girls) around the age of 15 years. They were able to correlate a polymorphism (variation in the shape) of the OPRM1 opioid receptor gene called A118G with heightened risk for alcohol-related problems and likelihood to meet the clinical diagnostic criteria for Alcohol Use Disorder (AUD).

Robert Miranda, Jr., assistant professor in the department of psychiatry and human behavior at Brown University and corresponding author for the study, commented on the implications of the study’s findings:

“Our current knowledge about the genetics of alcohol misuse during adolescence comes almost exclusively from family and twin studies. … But the relative importance of environmental and genetic factors appears to shift considerably over the course of adolescence … with genetics playing an important role once teenagers begin to drink. … Our findings provide the first evidence to suggest that teenagers who carry a certain variant of the OPRM1 gene experience more alcohol-related problems.”

Notably, the Brown University team discovered that teens with this variant were more likely to report drinking alcohol because of the pleasurable effects than for other reasons. The fact that the genetic variation enhances the pleasure experienced by youth when consuming alcohol helps to explain why teens with this variation might be more likely to develop problem drinking behaviors.

Miranda, Jr., explains, “The G allele, or variant, of the OPRMI gene is associated with the function of the body’s own natural opiate system. Research suggests that the G allele is associated with experiencing more pleasure and greater intoxication after drinking.”

By Emily Battaglia

Filed Under: drug addiction, Recovery · Tagged: , , , , , , , , , ,
Newer Posts »